Literature DB >> 6438743

Comparison of long acting oxytetracycline and parvaquone in immunisation against East Coast fever by infection and treatment.

T T Dolan, A Linyonyi, S K Mbogo, A S Young.   

Abstract

Two groups of five cattle were immunised with a field isolate of Theileria parva as stabilate and simultaneously treated with long acting oxytetracycline or parvaquone in early clinical disease. The oxytetracycline group suffered a marked fall in leucocyte count and one animal died during immunisation. The parvaquone group suffered a less severe fall in leucocyte count and all survived. The surviving immunised cattle were immune to homologous challenge but susceptible to subsequent challenge with T p lawrencei.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438743

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  4 in total

1.  Immune CD4+ T cells specific for Theileria parva-infected lymphocytes recognize a 24-kilodalton protein.

Authors:  D J Grab; C L Baldwin; W C Brown; E A Innes; J D Lonsdale-Eccles; Y Verjee
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Immunization with Theileria parva parasites from buffaloes results in generation of cytotoxic T cells which recognize antigens common among cells infected with stocks of T. parva parva, T. parva bovis, and T. parva lawrencei.

Authors:  T M Kariuki; J G Grootenhuis; T T Dolan; R P Bishop; C L Baldwin
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected bovine lymphoblasts and production of interferon by parasitized cells.

Authors:  J C DeMartini; C L Baldwin
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Epidemiological observations on theileriosis following field immunisation using infection and treatment.

Authors:  J J Mutugi; A S Young; D P Kariuki; J M Tameno; S P Morzaria
Journal:  Trop Anim Health Prod       Date:  1991-05       Impact factor: 1.559

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.